“Pancreas cancer: Genomics and biomarkers and Updates on Systemic Therapy for HCC”

Friday, October 13, 2017

Walker Auditorium (Live)

AZ PX CB 02 304 (Video Conference)

MN RO MA 11 00 4 ROOM F (Video Conference)

12:30 p.m. – 1:30 p.m. EST

Lunch available on a first come, first served basis in FL

Presented by:

Ghassan Abou-Alfa, MD, MBA

Associate Professor of Medicine

Eileen M. O'Reilly, M.D.

Associate Director

Hematology/Oncology

Memorial Sloan Kettering Cancer Center


Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Discuss new findings regarding the genomics of pancreas cancer and impacts on treatment options.
• Discuss new data regarding novel targeted therapies for HCC.
• Discuss new data regarding immunotherapy for HCC.

  “Speakers Doctor Ghassan Abou-Alfa and Doctor Eileen M. O’Reilly, have financial relationships to disclose and intend to discuss off-label/ investigational use of a commercial product device.”

  The Planning Committee members: Dr. James Foran, Jennifer Gatchell, Valerie Fernandez, and Linda Gibson have no relevant financial relationships to disclose.

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326)

• For further information, contact  Jen Gatchell 3-2795